Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MD
- 1 April 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 50 (4), 360-366
- https://doi.org/10.1097/qai.0b013e318198a800
Abstract
Background: We characterized patterns of highly active antiretroviral therapy (HAART) use and predictors of nonstructured treatment interruptions (NTIs) among injection drug users (IDUs) in Baltimore, MD. Methods: Three hundred thirty-five IDUs who initiated HAART from 1996 to 2006 were studied. NTIs were defined as any subsequent 6-month interval where HAART was not reported. Predictors of the first NTI and subsequent restart of HAART were examined using Cox regression. Results: Two hundred sixty (78%) reported ≥1 NTI. Of 215 with ≥1 follow-up visit after the NTI, 44 (20%) never restarted HAART, 62 (29%) restarted and remained on HAART, and 109 (51%) reported multiple NTIs. NTIs were less likely among those who initiated HAART in later calendar years and had a recent outpatient visit and more likely among women, persons with detectable HIV RNA at the prior visit, and those who reported injecting daily. Among those with NTIs, interuptions occurred earlier in persons who were younger, who did not have a prior AIDS diagnosis, and who were actively injecting; NTIs lasted longer in persons who had higher HIV RNA levels, in persons who were incarcerated, and in persons drinking alcohol. A recent outpatient visit and not actively injecting were associated with restarting HAART. Conclusions: NTIs were common in this population and occurred most frequently in the setting of active drug use and disruption of health care. Effective linkages between primary care for HIV and substance abuse treatment may improve HAART outcomes in this population.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Drug Abuse Treatment Modalities on Adherence to ART/HAART Among a Cohort of HIV Seropositive WomenThe American Journal of Drug and Alcohol Abuse, 2008
- Improving Survival among HIV-Infected Injection Drug Users: How Should We Define Success?Clinical Infectious Diseases, 2007
- Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohortsAIDS Research and Therapy, 2007
- Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug usersAIDS Care, 2007
- CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialThe Lancet, 2006
- Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adultsEmergencias, 2006
- Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral TherapyAmerican Journal of Epidemiology, 2006
- Effectiveness of Highly Active Antiretroviral Therapy among Injection Drug Users with Late-Stage Human Immunodeficiency Virus InfectionAmerican Journal of Epidemiology, 2005
- Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998